97473474 - X SCRIBE THERAPEUTICS

Information

  • Trademark
  • 97473474
  • Serial Number
    97473474
  • Filing Date
    June 23, 2022
    2 years ago
  • Transaction Date
    December 16, 2024
    a month ago
  • Status Date
    June 11, 2024
    7 months ago
  • Published for Opposition Date
    April 25, 2023
    a year ago
  • Location Date
    June 20, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    DIBLE, IAN
  • Attorney Docket Number
    333322.20000
    Attorney Name
    John Paul Oleksiuk
    Law Office Assigned Location Code
    M20
  • Owners
Mark Drawing Code
3
Mark Identification
X SCRIBE THERAPEUTICS
Case File Statements
  • DM0000: The mark consists of the stylized wordings "SCRIBE" above "THERAPEUTICS", all to the right of a stylized letter "X" partially formed by horizontal lines displayed atop a circle outline.
  • CC0000: Color is not claimed as a feature of the mark.
  • DS0000: "THERAPEUTICS"
  • GS0421: Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engineered cells for use in scientific research and in drug discovery and development; Providing medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering; Molecular diagnostic services in the nature of genetic testing for medical research purposes
Case File Event Statements
  • 7/12/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/27/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/13/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/9/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/16/2023 - a year ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/16/2023 - a year ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/16/2023 - a year ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/16/2023 - a year ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/16/2023 - a year ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/5/2023 - a year ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/25/2023 - a year ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/25/2023 - a year ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/20/2023 - a year ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/10/2023 - a year ago
    14 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/10/2023 - a year ago
    15 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/10/2023 - a year ago
    16 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 6/11/2024 - 7 months ago
    18 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/11/2024 - 7 months ago
    20 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/11/2024 - 7 months ago
    19 - SOU EXTENSION 2 FILED Type: EXT2
  • 6/13/2024 - 7 months ago
    21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/12/2023 - a year ago
    17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/15/2024 - a month ago
    22 - SOU TEAS EXTENSION RECEIVED Type: EEXT